Raman Singh Sells 8,468 Shares of Liquidia (NASDAQ:LQDA) Stock

Liquidia Corporation (NASDAQ:LQDA) Director Raman Singh sold 8,468 shares of the company’s stock in a transaction on Monday, September 14th. The shares were sold at an average price of $66.16, for a total transaction of $560,242.88. Following the sale, the director directly owned 44,637 shares in the company, valued at $2,953,183.92. This trade represents a 15.95% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Raman Singh also recently made the following trade(s):

• On Friday, September 11th, Raman Singh sold 9,024 shares of Liquidia stock. The shares were sold at an average price of $68.62, for a total value of $619,226.88.

Liquidia Trading Up 0.6%

NASDAQ LQDA traded up $0.41 during trading hours on Tuesday, hitting $65.72. 1,372,017 shares of the company’s stock were exchanged, compared to its average volume of 1,724,839. The stock has a 50-day simple moving average of $77.19 and a 200 day simple moving average of $59.67. Liquidia Corporation has a 1-year low of $21.15 and a 1-year high of $93.61. The firm has a market cap of $5.88 billion, a price-to-earnings ratio of 47.97 and a beta of 0.53. The company has a current ratio of 2.31, a quick ratio of 2.12 and a debt-to-equity ratio of 0.63.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The business had revenue of $171.68 million during the quarter, compared to analyst estimates of $168.48 million. During the same period last year, the firm posted ($0.49) earnings per share. Liquidia’s quarterly revenue was up 1842.1% compared to the same quarter last year. On average, equities analysts forecast that Liquidia Corporation will post 2.57 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have weighed in on LQDA shares. HC Wainwright set a $36.00 price objective on shares of Liquidia in a report on Friday, July 24th. Zacks Research cut shares of Liquidia from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 13th. Royal Bank Of Canada set a $130.00 price target on Liquidia in a research note on Friday, July 24th. Oppenheimer set a $75.00 price objective on Liquidia in a report on Friday, June 5th. Finally, Raymond James Financial reissued a “strong-buy” rating and issued a $106.00 price objective on shares of Liquidia in a research note on Thursday, August 13th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, three have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $98.08.

Hedge Funds Weigh In On Liquidia

Institutional investors have recently modified their holdings of the business. Covestor Ltd increased its position in shares of Liquidia by 41.9% during the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after acquiring an additional 359 shares during the last quarter. PNC Financial Services Group Inc. grew its stake in Liquidia by 7.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock valued at $217,000 after purchasing an additional 422 shares during the period. Quantinno Capital Management LP grew its stake in Liquidia by 3.6% in the 1st quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock valued at $648,000 after purchasing an additional 589 shares during the period. ProShare Advisors LLC grew its position in Liquidia by 7.1% during the fourth quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock valued at $405,000 after buying an additional 775 shares during the period. Finally, Arizona State Retirement System increased its holdings in Liquidia by 5.4% during the second quarter. Arizona State Retirement System now owns 17,627 shares of the company’s stock worth $1,405,000 after buying an additional 900 shares during the last quarter. 64.54% of the stock is owned by institutional investors.

About Liquidia

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing medicines for patients with serious cardiopulmonary conditions, including pulmonary arterial hypertension (PAH). The company is headquartered in Research Triangle Park, North Carolina, and serves healthcare providers and patients primarily in the United States.

Liquidia’s lead product is Yutrepia, an inhaled formulation of treprostinil designed for the treatment of PAH. The company has also developed treprostinil injection products and is pursuing additional therapies for rare cardiopulmonary diseases.